Redpoint Investment Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$222K Buy
+2,927
New +$222K 0.03% 541
2021
Q4
Sell
-2,127
Closed -$247K 651
2021
Q3
$247K Hold
2,127
0.02% 601
2021
Q2
$472K Buy
2,127
+527
+33% +$117K 0.04% 472
2021
Q1
$211K Hold
1,600
0.02% 637
2020
Q4
$277K Buy
+1,600
New +$277K 0.03% 494